J&J Increases European Consumer Stake With Merck Buyout
This article was originally published in The Tan Sheet
Executive Summary
Merck says it will seek new partners for future Rx-to-OTC switch drugs in Europe following Johnson & Johnson's buyout of the company's half of their European consumer health joint venture
You may also be interested in...
Tylenol Gains On COX-2 Fallout, Drives J&J Consumer Sales
Tylenol first-quarter sales benefited from the publicity surrounding COX-2 safety issues, according to Johnson & Johnson
Tylenol Gains On COX-2 Fallout, Drives J&J Consumer Sales
Tylenol first-quarter sales benefited from the publicity surrounding COX-2 safety issues, according to Johnson & Johnson
Tylenol Gains On COX-2 Fallout, Drives J&J Consumer Sales
Tylenol first-quarter sales benefited from the publicity surrounding COX-2 safety issues, according to Johnson & Johnson